Based on advance technology, Ortho-heal is a specialized medical device company that offers a unique medical solution. We invest our profits into improving the quality of life of many patients through our excellent research infrastructure. By building a global network with related organizations we are able to become a leading company that fuses IT, BT and NT that allows for : high quality technological development to propel us into the future.

CEO GREETING

Since its foundation in 2014, Orthoheal has been continuously improving its R&D department. After years of studying, finally we release our cosmetic device, Inerskin to you.
Inerskin has been clinically proved its effectiveness, such as improvement of moisturizing, whitening, antiwrinkle by absorbing deeper into your skin. Our main technology, which is Orthoheal X-TECH has been developed based on Drug delivery system(DDS) to deliver active ingredient into the skin.

 

“Using INERSKIN, Get younger.”

 

Orthoheal is 1st subsidiary of Korea University Medical Holdings Company, we are pursing the development of total solution in Cosmeceutical industry with accumulated various patents. We were mainly focused on research, however, according to public demand, we have decided to release inerskin.
Currently we are developing a skin booster for boldness, obesity, scar, arthritis, and tendinitis, and Nano Lyposome cosmetics and will release them in the near future.
As a customer-friendly company, Orthoheal will continuously offer total beauty and health solution to customers with its combined medical and beauty technology.

CEO. Hae-Ryong Song, Joo-Young Song

BUSINESS AREA

BMP-2

Bone and cartilage formation
using strong bone formation
inducing agents

Microsphere/Nanoparticles

– Potential for sustained drug delivery
– Target specific area for the desired
treatment outcome

Ultrasound bone healing device

– Fracture treatment
– Pain reduction (analgesic effect)
– Osteoarthritis treatment
– Connective tissue treatment

Skin booster

Efficient drug delivery through
multiple frequency
electroporation

HISTORY

Year

Main contents
2011.05
- The fusion therapy center for Bone defect/disease project selection(7billion won, 5years(Ossgen, khanmedi, Orthoheal))
2013.08
- Bone morphgenic protein-2 (BMP2) preclinical trial completed
2013.11
- Selection of soft tissue regeneration project (3 billion won, Total 6 years)
2014.11
- Ortho-heal Co., Ltd. Establish (Korea University Medical Holding Company Subsidiary No.1)
2015.08
- Ultrasound Bone Healing Device (BH1000 Release & Sales, Medical Device Class Ⅱ)
2015.12
- Capital increase by issuing new stock (253 million won)
2016.08
- Capital increase by issuing new stock (315 million won)- Certificate of R&D Institute (MSIP)
2016.09
- Invest at synergy IB Inv. Co., Ltd. 300 million won (615 million won)- Ultrasound Bone Healing Device (BH2000) development
2016.10
- Certificate of Venture Business (KVCA)
2016.12
- GMP certification
2017.03
- TIPS program – A research fund 500 million won, Attraction of investment of 400 million won for commercialization and overseas marketing
INERSKIN by Orthheal

CONTACT